EUVIMEDEUVIMED entdecken
Crossref

PAI-1 as a Therapeutic Target: A State-of-the-Art Review

Jacob Wortley iD, Lily Crone, Neha Soogoor, Mebeli Becerra, Justin Vu, Mohanakrishnan Sathyamoorthy

Seminars in Thrombosis and Hemostasis · 11.08.2026

DOI: 10.1055/a-2924-5438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Seminars in Thrombosis and Hemostasis, online erschienen am 11.08.2026. Verfasst von Jacob Wortley und 5 weiteren Autor:innen. Beteiligte Einrichtung: Texas Christian University Anne Burnett Marion School of Medicine, Department of Medicine, Texas, United States, Fort Worth.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractPlasminogen activator inhibitor (PAI-1) is a member of the serine protease inhibitor family critical in regulating fibrinolysis and is associated with diverse pathologies including cardiovascular disease, metabolic disorders, cancer, aging, and many others. Despite its clinical significance and extensive research, there are as of yet still no FDA- or EMA-approved therapeutics that specifically target PAI-1. This review examines therapeutic strategies including small molecules, RNA aptamers, monoclonal antibodies, and repurposed pharmaceuticals. Notable challenges in the development of these therapies include the interplay of PAI-1 with tissue-specific mediators such as vitronectin and the multi-dimensional, tissue-specific effects of PAI-1 modulation. Promising approaches will require tissue- and temporal expression-based interventions. Further characterization of PAI-1's structural dynamics and its role in various disease processes will shape its potential as a therapeutic target across broad fields in medicine.

Autor:innen und Institutionen

  • Texas Christian University Anne Burnett Marion School of Medicine, Department of Medicine, Texas, United States, Fort Worth.
  • Consultants in Cardiovascular Medicine and Science, Department of Medicine, Texas, United States, Fort Worth.

ORCID-Profile: Jacob Wortley

Zitieren

APA

Wortley, J., Crone, L., Soogoor, N., Becerra, M., Vu, J., & Sathyamoorthy, M. (2026). PAI-1 as a Therapeutic Target: A State-of-the-Art Review. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/a-2924-5438

Vancouver

Wortley J, Crone L, Soogoor N, Becerra M, Vu J, Sathyamoorthy M. PAI-1 as a Therapeutic Target: A State-of-the-Art Review. Seminars in Thrombosis and Hemostasis. 2026. doi:10.1055/a-2924-5438

BibTeX
@article{Wortley2026,
  author = {Wortley, Jacob and Crone, Lily and Soogoor, Neha and Becerra, Mebeli and Vu, Justin and Sathyamoorthy, Mohanakrishnan},
  title = {PAI-1 as a Therapeutic Target: A State-of-the-Art Review},
  journal = {Seminars in Thrombosis and Hemostasis},
  year = {2026},
  doi = {10.1055/a-2924-5438}
}
Kostenlos starten →